HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7

Benzinga Newsdesk www.benzinga.com Positive 53.2%

Neg 0% Neu 0% Pos 53.2%

HC Wainwright & Co. analyst Yi Chen initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $7.